|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
8
|
|
pubmed:dateCreated |
2004-8-13
|
|
pubmed:abstractText |
Two main subpopulations of human blood monocytes are distinguished on the basis of CD14 and CD16 expression: the major population with enhanced expression of CD14 (CD14++ monocytes) and the minor one with a weak expression of CD14 coexpressing CD16 (CD14+/CD16+ monocytes). As monocytes and macrophages are involved in antitumor response of the host, we assessed the ability of CD14+/CD16+ monocytes to produce cytokines (intracellular expression, release) and reactive oxygen and nitrogen (ROI, RNI) intermediates following stimulation in vitro with tumor cells.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
0301-472X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
32
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
748-55
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:15308326-Antigens, CD14,
pubmed-meshheading:15308326-Cell Line, Tumor,
pubmed-meshheading:15308326-Cytokines,
pubmed-meshheading:15308326-Cytotoxicity, Immunologic,
pubmed-meshheading:15308326-Humans,
pubmed-meshheading:15308326-Monocytes,
pubmed-meshheading:15308326-Nitric Oxide,
pubmed-meshheading:15308326-Reactive Nitrogen Species,
pubmed-meshheading:15308326-Reactive Oxygen Species,
pubmed-meshheading:15308326-Receptors, IgG
|
|
pubmed:year |
2004
|
|
pubmed:articleTitle |
Antitumor response of CD14+/CD16+ monocyte subpopulation.
|
|
pubmed:affiliation |
Department of Clinical Immunology, Polish-American Institute of Pediatrics, Jagiellonian University Medical College, Cracow, Poland.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
